HIV Tat protein causes endothelial dysfunction in porcine coronary arteries

Journal of Vascular Surgery

Volumn 38, Issue 3, 2003, Pages 549-555

  Paladugu, Ramesh ^a,b   Fu, Weiping ^a,b   Conklin, Brian S ^a,b   Lin, Peter H ^a,b   Lumsden, Alan B ^a,b   Yao, Qizhi ^a,b   Chen, Changyi ^a,b,c   Geary, Randolph ^a  

^a Methodist Hospital ^*

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BRADYKININ; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITROPRUSSIDE SODIUM; TRANSACTIVATOR PROTEIN; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOREACTIVITY; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE CONTRACTILITY; SWINE; VASODILATATION; WESTERN BLOTTING; ANIMAL; ANIMAL MODEL; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; CULTURE TECHNIQUE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; BRADYKININ; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; CULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; GENE PRODUCTS, TAT; IMMUNOHISTOCHEMISTRY; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; RANDOM ALLOCATION; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SWINE; VASOCONSTRICTION; VASODILATION;

EID: 0141835815     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00770-5     Document Type: Article

References (39)

1. Joshi VV, Pawel B, Conner E, et al. Arteriopathy in children with AIDS. Pediatr Pathol 1987;7:261-75.
2. Paton P, Tabib A, Loire R, Tete R. Coronary artery lesions and human immunodeficiency virus infection. Res Virol 1993;144:225-31.
3. Tabib A, Leroux C, Momex JF, Loire R. Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus- positive patients. Coronary Artery Dis 2000;11:41-6.
4. Constants J, Marchand JM, Conri C, Penchant E, Seigneur M, Rispal P, et al. Asymptomatic atherosclerosis in HIV-positive patients: a case-control ultrasound study. Ann Med 1995;27:683-5.
5. Nair R, Robbs JV, Chetty R, Naidoo NG, Woolgar J. Occlusive arterial disease in HIV-infected patients: a preliminary report. Eur J Vasc Eudovasc Surg 2000;20:353-7.
6. Berger JR, Harris JO, Gregorios J, Norenberg M. Cerebrovascular disease in AIDS: a case-control study. AIDS 1990;4:239-44.
7. Connor MD, Lammie GA, Bell JE, Warlow CP, Simmonds P, Brettle RD. Cerebral infarction in adult AIDS patients. Stroke 2002;31:2117-26.
8. Grunfeld C, Kotler DP, Hamadeh R, Tiemey A, Wang J, Pierson RN. Hypertriglycerdemia in the acquired immunodeficiency syndrome. Am J Med 1989;86:27-31.
9. Bussolino F, Mitola S, Serini G, Barillari G, Ensoli B. Interactions between endothelial cells and HIV-1. Int J Biochem Biol 2001;33:371-90.
10. Chi D, Henry J, Kelley J, Thorpe R, Smith JK, Krishnaswamy G. The effects of HIV infection on endothelial function. Endothelium 2000;7: 223-42.
11. Song CZ, Loewenstein PM, Green M. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s). Proc Natl Acad Sci USA 1994;91:9357-61.
12. Ansari SA, Safak M, Gallia GL, Sawaya BE, Amini S, Khalili K. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity. J Gen Virol 1999;80:2629-38.
13. Sawaya BE, Khalili K, Gordon J, Taube R, Amini S. Cooperative interaction between HIV-1 regulatory proteins tat and vpr modulates transcription of the viral genome. J Biol Chem 2000;275:35209-14.
14. Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B. HIV-1 tat protein exits from cells via a leaderless secretory pathway and binds to extracellelar matrix-associated heparan sulfate proteoglycan through its basic region. AIDS 1997;11:1421-31.
15. Hofman FM, Chen P, Incardona F, Zidovetzki R, Hinton DR. HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells. J Neuroimmunol 1999;1:28-39.
16. Dhawan S, Puri RK, Kumar A, Duplan H, Masson JM, Aggarwal BB. Human immunodeficiency virus-1-Tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 1997;90:1535-44.
17. Conklin BS, Surowiec SM, Ren ZG, Li J, Zhong DS, Lumsden AB, et al. Effects of nicotine and cotanine on porcine arterial endothelial cell function. J Surg Res 2001;95:23-31.
18. Surowiec SM, Conklin BS, Li LS, Lin PH, Lumsden AB, Chen C. A new perfusion culture system used to study human vein. J Surg Res 2000;88:34-7.
19. Zhong DS, Lu XH, Conklin BS, Lin PH, Lumsden AB, Yao Q, et al. HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol 2002;22:1560-4.
20. Conklin BS, Zhong DS, Zhao WD, Lin PH, Chen C. Shear stress regulates occludin and VEGF expression in porcine arterial endothelial cells. J Surg Res 2002;102:13-7.
21. Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993;70:36-41.
22. Lamas S, Perez-Sala D, Moncada S. Nitric oxide: from discovery to the clinic. Trends Pharmacol Sci 1998;19:436-41.
23. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-4.
24. Ludmer PL, Selwyn AP, Shook TL, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-50.
25. Benzuly KH, Padgett RC, Kaul S, Piegors DJ, Armstrong ML, Heistad DD. Functional improvement precedes structural regression of atherosclerosis. Circulation 1994;89:1810-5.
26. Singer H, Peach M. Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension 1982;3:19-23.
27. Pelc LR, Gross GJ, Warltier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 1991;83:2048-52.
28. Bobryshev YV, Cherian SM, Tran D. Identification of HIV-1 in the aortic wall of AIDS patients. Atherosclerosis 2000;152:529-30.
29. Mitola S, Soldi R, Zanon I, Barra L, Gutierrez MI, Berkhout B, et al. Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. J Virol 2000;74:344-53.
30. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1995;92:4838-42.
31. Park IW, Ullrich CK, Schoenberger E, Gasnju RK. HIV-1 Tat induces micro vascular endothelial apoptosis through caspase activation. J Immunol 2001;167:2766-71.
32. Jia H, Lohr M, Jezequel S, Daws D, Shaikh S, Selwood D, et al. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Biochem Biophys Res Commun 2001;283:469-79.
33. Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, Walker SM. Exogenous tat protein activates human endothelial cells. Blood 1993; 82:2774-80.
34. Arese M, Ferrandi C, Primo L, Camussi G, Bussolino F. HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomonuclear cell recruitment. J Immunol 2001;166:1380-8.
35. Toschi E, Barillari G, Sgadari C, Bacigalupo I, Cereseto A, Carlei D, et al. Activation of matrix-metalloproteinase-2 and membrane-type-1 matrix metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol Biol Cell 2001;12:2934-46.
36. Cota-Gomez A, Flores NA, Cruz C, Casullo A, Aw TY, Ichikawa H, et al. The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-κB-dependent mechanism. J Biol Chem 2002;277:17:14390-9.
37. Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA. Role of nuclear factor-kappa B in atherogenesis. Exp Physiol 1997;82:297-304.
38. Acevedo M, Sprecher DL, Calabrese L, Pearce GL, Coyner DL, Halliburton SS, et al. Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: a call for cardiovascular prevention. Atherosclerosis 2002;163:349-54.
39. Dube MP, Sprecher D, Henry WK, et al. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clin Infect Dis 2000;31:1216-24.